Zentek(NASDAQ) ZTEK

Market Cap$73.68M

Since IPO (2012)+80%

5 Year-74%

1 Year-19%

1 Month+26%

$0.58

-0.33%

-0.00Today

Zentek last closing stock price
Metric	Price	Date
Last close	USD 0.58	2026-08-19

Zentek stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-7.52%	USD 0.63	2026-08-12
1 month	+26.47%	USD 0.46	2026-07-20
3 month	-19.07%	USD 0.72	2026-05-21
Year to date	-9.08%	USD 0.64	2025-12-31
1 year	-19.19%	USD 0.72	2025-08-19
3 year	-58.14%	USD 1.39	2023-08-18
5 year	-74.14%	USD 2.25	2021-08-20
Since inception	+80.15%	USD 0.32	2012-03-30

Zentek Financials at a Glance

Market Cap

$73.68M

Revenue (TTM)

CA$108.29K

Net Income (TTM)

-CA$10.46M

EPS (TTM)

-$0.07

P/E Ratio

-8.32

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$0.58

Volume

3,372.898

Open

$0.56

Price

$0.58

Volume

3,372.898

Open

$0.56

Previous Close

$0.58

Daily Range

$0.56 - $0.58

52-Week Range

$0.37 - $1.24

Estimated Earnings Date

Nov 12, 2026

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$0.58

Volume

3,372.898

Open

$0.56

Previous Close

$0.58

Daily Range

$0.56 - $0.58

52-Week Range

$0.37 - $1.24

Estimated Earnings Date

Nov 12, 2026

ZTEK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zentek

Zentek Ltd. is a Canadian company focused on the research and development of graphene and related nanomaterials. The company specializes in innovative products, including antimicrobial coatings, surgical masks, and rapid diagnostic tests.

Products and Services

Graphene-based antimicrobial coatings under the ZenGUARD brand
Surgical masks and personal protective equipment
Rapid detection point-of-care diagnostic tests

Growth Outlook

Expansion into the healthcare sector with innovative graphene-based products
Development of the Albany graphite project to enhance production capabilities
Increasing demand for advanced materials in various industries

Financial Highlights

Recent quarterly revenue of CAD 36,861, showing potential for growth
Trailing twelve months (TTM) revenue of CAD 81,359, indicating upward momentum
Cash and cash equivalents of CAD 1,306,104, providing operational flexibility

Zentek Ltd. operates in the promising field of graphene technology, which is gaining traction across multiple sectors. The company's focus on developing advanced materials positions it well for future growth, particularly in healthcare and environmental applications. Recent financial data reflects a commitment to innovation, with a notable increase in revenue over the trailing twelve months. The Albany graphite project further enhances the company's potential by securing a critical resource for its product development. With a solid cash position, Zentek is poised to capitalize on emerging opportunities in the market.

AI Generated • Aug 19, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Mohammed Jiwan

Website

www.zentek.com

Headquarters

Guelph, ON N1E 6Z1, CA

ZTEK Financials

Key Financial Metrics (TTM)

Gross Margin

-5018.33%

Operating Margin

-10055.02%

Net Income Margin

-9652.83%

Return on Equity

-70.73%

Return on Capital

-92.44%

Return on Assets

-33.86%

Earnings Yield

-12.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$73.68M

Shares Outstanding

126.62M

Volume

3.37K

Avg. Volume

181.40K

Financials (TTM)

Gross Profit

-CA$5.44M

Operating Income

-CA$10.89M

EBITDA

-CA$10.62M

Operating Cash Flow

-CA$5.08M

Capital Expenditure

-CA$325.25K

Free Cash Flow

-CA$5.40M

Cash & ST Invst.

CA$16.60M

Total Debt

CA$1.93M

Zentek Performance Analysis

Zentek annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-03-31	CAD 55,073	-79.7%
2024	2024-03-31	CAD 22,105	-59.9%
2025	2025-03-31	CAD 627,271	2737.7%
2026	2026-03-31	CAD 120,142	-80.8%

Zentek sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-09-30	-89.3%
Q3	2025-12-31	951.3%
Q4	2026-03-31	-43.5%
Q1	2026-06-30	-100.0%

Zentek annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-03-31	CAD -0.11	-60.1%
2024	2024-03-31	CAD -0.09	-21.3%
2025	2025-03-31	CAD -0.07	-18.8%
2026	2026-03-31	CAD -0.07	-4.9%

Zentek sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-09-30	-53.8%
Q3	2025-12-31	-16.5%
Q4	2026-03-31	-40.8%
Q1	2026-06-30	45.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CA$0.00

-100.0%

Gross Profit

-CA$1.22M

-4596.4%

Gross Margin

0.00%

N/A

Market Cap

$73.68M

N/A

Market Cap/Employee

$7.37M

N/A

Employees

N/A

Net Income

-CA$2.04M

-50.1%

EBITDA

-CA$2.06M

-76.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

CA$16.60M

+474.8%

Total Debt

CA$1.93M

+2.7%

Accounts Receivable

CA$391.95K

-0.6%

Inventory

CA$393.66K

-55.9%

Long Term Debt

CA$1.81M

+6.7%

Short Term Debt

CA$115.22K

-35.2%

Return on Assets

-33.86%

N/A

Return on Invested Capital

-40.20%

N/A

Free Cash Flow

-CA$1.18M

+3.9%

Operating Cash Flow

-CA$1.18M

-0.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HYPRHyperfine, Inc.

HYPRHyperfine, Inc.$0.90-0.21%

MBOTMicrobot Medical Inc.

MBOTMicrobot Medical Inc.$1.51-2.62%

HYFTMindWalk Holdings Corp.

HYFTMindWalk Holdings Corp.$1.42-2.07%

MGXMetagenomi, Inc. Common Stock

MGXMetagenomi, Inc. Common Stock$1.23-0.81%

GUTSFractyl Health, Inc.

GUTSFractyl Health, Inc.$0.69+0.31%

BYSIBeyondSpring Inc.

BYSIBeyondSpring Inc.$0.73+0.98%

QNCXQuince Therapeutics, Inc.

QNCXQuince Therapeutics, Inc.$34.18-1.13%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$40.72+0.05%

MRNAModerna

MRNAModerna$138.24-0.21%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$133.45-0.04%

WMTWalmart

WMTWalmart$104.46-0.09%

INTCIntel

INTCIntel$90.58-0.02%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$21.56+0.06%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$9.72+0.05%

Questions About ZTEK

What is the current price of Zentek?

Zentek is trading at $0.58 per share.

What is the 52-week range for Zentek?

Over the past 52 weeks, Zentek has traded between $0.37 and $1.24.

How much debt does Zentek have?

As of the most recent reporting period, Zentek reported total debt of CA$1.36M.

How much cash does Zentek have on hand?

Zentek reported CA$11.70M in cash and cash equivalents in its most recent financial results.

What is Zentek’s dividend yield?

Zentek does not currently have a dividend yield.

Zentek(NASDAQ) ZTEK

Zentek Financials at a Glance

ZTEK News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Zentek

ZTEK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Zentek Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ZTEK

What is the current price of Zentek?

What is the 52-week range for Zentek?

How much debt does Zentek have?

How much cash does Zentek have on hand?

What is Zentek’s dividend yield?

Premium Investing Services